Cargando…

Cell-Based Therapies for Heart Failure

Heart failure has reached epidemic proportions with the advances in cardiovascular therapies for ischemic heart diseases and the progressive aging of the world population. Efficient pharmacological therapies are available for treating heart failure, but unfortunately, even with optimized therapy, pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Campos de Carvalho, Antonio Carlos, Kasai-Brunswick, Tais H., Bastos Carvalho, Adriana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072383/ https://www.ncbi.nlm.nih.gov/pubmed/33912054 http://dx.doi.org/10.3389/fphar.2021.641116

Ejemplares similares

Stem cell therapies in cardiac diseases: Current status and future possibilities
por: Kasai-Brunswick, Tais Hanae, et al.
Publicado: (2021)

Proteomics in the World of Induced Pluripotent Stem Cells
por: Lindoso, Rafael Soares, et al.
Publicado: (2019)

Hair follicle-derived mesenchymal cells support undifferentiated growth of embryonic stem cells
por: Coelho de Oliveira, Vanessa Carvalho, et al.
Publicado: (2017)

Stem Cell-Based Therapies in Chagasic Cardiomyopathy
por: Campos de Carvalho, Antonio Carlos, et al.
Publicado: (2015)

Cardiosphere-derived cells do not improve cardiac function in rats with cardiac failure
por: Kasai-Brunswick, Taís Hanae, et al.
Publicado: (2017)

Bone-Marrow-Derived Mesenchymal Stromal Cells (MSC) from Diabetic and Nondiabetic Rats Have Similar Therapeutic Potentials
por: José, Vitória Santório de São, et al.
Publicado: (2017)

Reprogramming to a pluripotent state modifies mesenchymal stem cell resistance to oxidative stress
por: Asensi, Karina D, et al.
Publicado: (2014)

Modelling premature cardiac aging with induced pluripotent stem cells from a hutchinson-gilford Progeria Syndrome patient
por: Monnerat, Gustavo, et al.
Publicado: (2022)

Empagliflozin reduces arrhythmogenic effects in rat neonatal and human iPSC-derived cardiomyocytes and improves cytosolic calcium handling at least partially independent of NHE1
por: Silva dos Santos, Danúbia, et al.
Publicado: (2023)

Integrin alpha-5 subunit is critical for the early stages of human pluripotent stem cell cardiac differentiation
por: Neiman, Gabriel, et al.
Publicado: (2019)

Pharmacological Tuning of Adenosine Signal Nuances Underlying Heart Failure With Preserved Ejection Fraction
por: Campos-Martins, Alexandrina, et al.
Publicado: (2021)

Trimetazidine in Heart Failure
por: Shu, Hongyang, et al.
Publicado: (2021)

Embryonic stem cell-derived cardiomyocytes for the treatment of doxorubicin-induced cardiomyopathy
por: Silva dos Santos, Danúbia, et al.
Publicado: (2018)

Identification of Natural Products as SENP2 Inhibitors for Targeted Therapy in Heart Failure
por: Taghvaei, Somayye, et al.
Publicado: (2022)

Granulocyte Colony-Stimulating Factor Treatment Before Radiotherapy Protects Against Radiation-Induced Liver Disease in Mice
por: Ramos, Isalira Peroba Rezende, et al.
Publicado: (2021)

Therapy with Cardiomyocytes Derived from Pluripotent Cells in Chronic Chagasic Cardiomyopathy
por: Brasil, Guilherme Visconde, et al.
Publicado: (2020)

Efficacy of pharmacologic therapies in patients with acute heart failure: A network meta-analysis
por: Dai, Hengheng, et al.
Publicado: (2022)

Immunomodulatory Treatment Strategies Targeting B Cells for Heart Failure
por: Zhang, Xinxin, et al.
Publicado: (2022)

Exogenous 10 kDa-Heat Shock Protein Preserves Mitochondrial Function After Hypoxia/Reoxygenation
por: Maciel, Leonardo, et al.
Publicado: (2020)

Reverse Remodeling in Human Heart Failure after Cardiac Resynchronization Therapy Is Associated With Reduced RHO-Kinase Activation
por: Ocaranza, Maria Paz, et al.
Publicado: (2021)

Epoxyeicosatrienoic Acid-Based Therapy Attenuates the Progression of Postischemic Heart Failure in Normotensive Sprague-Dawley but Not in Hypertensive Ren-2 Transgenic Rats
por: Hrdlička, Jaroslav, et al.
Publicado: (2019)

Cyclic GMP and PKG Signaling in Heart Failure
por: Numata, Genri, et al.
Publicado: (2022)

Mechanism of Chinese Medicine Herbs Effects on Chronic Heart Failure Based on Metabolic Profiling
por: Gao, Kuo, et al.
Publicado: (2017)

Factors Associated With Hospital Readmission of Heart Failure Patients
por: Al-Tamimi, Maitha Abdul-Aziz, et al.
Publicado: (2021)

Circulating Circular RNAs: Novel Biomarkers for Heart Failure
por: Sun, Chuan, et al.
Publicado: (2020)

The Role of Myocardial Mitochondrial Quality Control in Heart Failure
por: Qiu, Zhiling, et al.
Publicado: (2019)

Mechanisms and Efficacy of Traditional Chinese Medicine in Heart Failure
por: Wang, Anzhu, et al.
Publicado: (2022)

Cost effectiveness analyses of pharmacological treatments in heart failure
por: Lim, Audrey Huili, et al.
Publicado: (2022)

Screening of anti-heart failure active compounds from fangjihuangqi decoction in verapamil-induced zebrafish model by anti-heart failure index approach
por: Li, Jun, et al.
Publicado: (2022)

Exploring the mechanism of anti-chronic heart failure effect of qiweiqiangxin І granules based on metabolomics
por: Zhong, Wanru, et al.
Publicado: (2023)

New Insights in Cardiac β-Adrenergic Signaling During Heart Failure and Aging
por: de Lucia, Claudio, et al.
Publicado: (2018)

Action potential variability in human pluripotent stem cell-derived cardiomyocytes obtained from healthy donors
por: Carvalho, A. B., et al.
Publicado: (2022)

Bone marrow cell migration to the heart in a chimeric mouse model of acute chagasic disease
por: Irion, Camila Iansen, et al.
Publicado: (2017)

A Novel Alginate-Based Delivery System for the Prevention and Treatment of Pressure-Overload Induced Heart Failure
por: Kumar, Ambrish, et al.
Publicado: (2021)

Identification of key pharmacodynamic markers of American ginseng against heart failure based on metabolomics and zebrafish model
por: Dong, Rong, et al.
Publicado: (2022)

Phosphoproteomic and proteomic profiling in post-infarction chronic heart failure
por: Wang, Jiayue, et al.
Publicado: (2023)

Trimetazidine Attenuates Heart Failure by Improving Myocardial Metabolism via AMPK
por: Shu, Hongyang, et al.
Publicado: (2021)

Association of thiamine administration and prognosis in critically ill patients with heart failure
por: Yang, Rui, et al.
Publicado: (2023)

Cost-effectiveness of empagliflozin for the treatment of heart failure: a systematic review
por: Liu, Jinyu, et al.
Publicado: (2023)

Prognostic Value of Pericardial Effusion Size in Patients with Acute Heart Failure
por: Zhai, Guangyao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8pia1spamtlue1ofb92js4ess3